The Effect of Proton Pump Inhibitor and Prokinetics Combination Therapy for Functional Dyspepsia

被引：0
|
作者：
Lee, Ju Yup [1 ]
机构：
[1] Keimyung Univ, Sch Med, Dept Internal Med, Daegu, South Korea
来源：
KOREAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 77卷 / 04期
关键词：
GASTRIC-CANCER;
D O I：
10.4166/kjg.2021.060
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：149 / 150
页数：2
相关论文
共 50 条
  • [31] Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway
    Huang, Shuling
    Chen, Min
    Ding, Xiwei
    Zhang, Xiaoqi
    Zou, Xiaoping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 17 (03) : 585 - 592
  • [32] Combination of talaporfin photodynamic therapy and Poly (ADP-Ribose) polymerase (PARP) inhibitor in gastric cancer
    Tanaka, Mamoru
    Sasaki, Makiko
    Suzuki, Taketo
    Nishie, Hirotada
    Kataoka, Hiromi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 539 : 1 - 7
  • [33] Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection-a randomized controlled study
    Kato, Tomohiro
    Araki, Hiroshi
    Onogi, Fumito
    Ibuka, Takashi
    Sugiyama, Akihiko
    Tomita, Eiichi
    Nagaki, Masahito
    Moriwaki, Hisataka
    JOURNAL OF GASTROENTEROLOGY, 2010, 45 (03) : 285 - 290
  • [34] Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis
    Niikura, Ryota
    Hayakawa, Yoku
    Hirata, Yoshihiro
    Yamada, Atsuo
    Fujishiro, Mitsuhiro
    Koike, Kazuhiko
    GUT, 2018, 67 (10) : 1908 - 1910
  • [35] Proton pump inhibitor pantoprazole inhibits the proliferation, self-renewal and chemoresistance of gastric cancer stem cells via the EMT/β-catenin pathways
    Feng, Shuitu
    Zheng, Zhigao
    Feng, Lihua
    Yang, Lihong
    Chen, Zuhong
    Lin, Yubiao
    Gao, Yingqin
    Chen, Yide
    ONCOLOGY REPORTS, 2016, 36 (06) : 3207 - 3214
  • [36] Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study
    Halfdanarson, Oskar O. E.
    Fall, Katja
    Ogmundsdottir, Margret H.
    Lund, Sigrun H.
    Steingrimsson, Eirikur
    Ogmundsdottir, Helga M.
    Zoega, Helga
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (04) : 471 - 478
  • [37] Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes
    Guan, Xu-Wen
    Zhao, Fang
    Wang, Jing-Ya
    Wang, Hai-Yan
    Ge, Shao-Hua
    Wang, Xia
    Zhang, Le
    Liu, Rui
    Ba, Yi
    Li, Hong-Li
    Deng, Ting
    Zhou, Li-Kun
    Bai, Ming
    Ning, Tao
    Zhang, Hai-Yang
    Huang, Ding-Zhi
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (09): : 1913 - +
  • [38] Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea
    Seo, Seung In
    Park, Chan Hyuk
    You, Seng Chan
    Kim, Jae Young
    Lee, Kyung Joo
    Kim, Jinseob
    Kim, Yerim
    Yoo, Jong Jin
    Seo, Won-Woo
    Lee, Hyung Seok
    Shin, Woon Geon
    GUT, 2021, 70 (11) : 2066 - 2075
  • [39] Antitumor Effect of Simvastatin in Combination With DNA Methyltransferase Inhibitor on Gastric Cancer via GSDME-Mediated Pyroptosis
    Xia, Ying
    Jin, Yong
    Cui, Daxiang
    Wu, Xia
    Song, Cunfeng
    Jin, Weilin
    Huang, Hai
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [40] Whether long-term use of proton pump inhibitor increases the risk of precancerous lesions in the stomach: A systematic review and meta-analysis of randomized controlled trials
    Lv, Fangyi
    Wang, Jincheng
    Mao, Leiming
    Zhou, Xiangyu
    Zhang, Taiwei
    Zhou, Sufang
    MEDICINE, 2023, 102 (38) : E35062
12345